Our study is in line with the previous reports confirming that germline mutation carriers of NM_000535.7:c.943C>T in the PMS2 gene are highly susceptible to developing Lynch syndrome-associated cancers, which was confirmed by IHC (Vaughn et al., 2010; Borràs et al., 2013). This evidence concerns the gene PMS2 and Lynch syndrome.